Arkolith/Insider Trading/ACAD/Form 4

Kihara James

PRINCIPAL ACCOUNTING OFFICERACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Apr 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 7, 2026Sell(S)1K$22.20$23K28K
Apr 5, 2026Option exercise(M)2K——29K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 5, 2026Option exercise(M)2K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001816160-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML